Recombinant Human GART Protein ，His

GART (Phosphoribosylglycinamide transformylase) is a crucial enzyme involved in the purine biosynthesis pathway, facilitating the conversion of phosphoribosylglycinamide to formylglycinamidine, an essential step in the de novo synthesis of purines. Research on GART has garnered significant attention due to its pivotal role in cellular metabolism and its potential implications in various diseases, particularly cancer, where altered nucleotide synthesis can lead to uncontrolled cell proliferation. The enzyme is part of a multi-functional protein complex that also includes aminoimidazole ribonucleotide (AIR) synthetase and phosphoribosylaminoimidazole carboxylase, collectively known as the GART-like proteins, which are studied for their complex regulation and interactions. Understanding GART’s structure and function at a molecular level can pave the way for novel therapeutic strategies aimed at inhibiting its activity in malignant tumors, as well as for the development of antibiotics targeting bacterial GART homologs. Recent advances in structural biology techniques, including X-ray crystallography and cryo-electron microscopy, have provided valuable insights into the enzyme's active site and substrate interactions, furthering the exploration of small-molecule inhibitors. As the understanding of purine metabolism deepens, GART continues to be an attractive target for drug discovery, with ongoing studies aimed at elucidating its role in health and disease.